IHC staining revealed that the metastatic NPC tumors had lower levels of SHROOM2 compared to the primary tumors (Fig. 3e), further supporting a suppressive role of SHROOM2 in NPC metastasis in vivo. The gene discussed is SHROOM2; the disease is nasopharyngeal carcinoma.